By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


XenoPort, Inc. 

3410 Central Expressway

Santa Clara  California  95051  U.S.A.
Phone: 408-616-7200 Fax: 408-616-7210


Company News
XenoPort, Inc. (XNPT) To Present At The 2015 Wells Fargo Healthcare Conference 9/2/2015 10:55:07 AM
XenoPort, Inc. (XNPT) Reports Second Quarter Financial Results 8/6/2015 11:48:57 AM
XenoPort, Inc. (XNPT) To Release Second Quarter Financial Results On August 5, 2015 7/27/2015 10:07:52 AM
XenoPort, Inc. (XNPT) Announces Initiation By NIAAA Of Clinical Trial Of HORIZANT In Patients With Alcohol Use Disorder 6/25/2015 12:25:42 PM
XenoPort, Inc. (XNPT) Release: HORIZANT (Gabapentin Enacarbil) Included In New Expert Recommendations On Prevention And Treatment Of RLS Augmentation 6/8/2015 10:55:30 AM
XenoPort, Inc. (XNPT) To Present New Pooled Data Analyses On HORIZANT (Gabapentin Enacarbil) At The 2015 SLEEP Annual Meeting 6/2/2015 1:31:18 PM
XenoPort, Inc. (XNPT) To Present At The Jefferies and Co. 2015 Global Healthcare Conference 5/18/2015 12:13:55 PM
XenoPort, Inc. (XNPT) Reports First Quarter Financial Results 5/7/2015 12:36:57 PM
XenoPort, Inc. (XNPT) To Release First Quarter Financial Results On May 6, 2015 4/29/2015 12:09:06 PM
XenoPort, Inc. (XNPT) To Present New Data Analyses For HORIZANT (gabapentin enacarbil) At The 67th Annual Meeting Of The American Academy of Neurology 4/15/2015 6:50:24 AM